Amanda Leiter
Amanda Leiter
Verified email at
Cited by
Cited by
Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and-negative breast cancer cells by modulating the EGFR/HER-2 pathway
NH Thoennissen, J O'kelly, D Lu, GB Iwanski, DT La, S Abbassi, A Leiter, ...
Oncogene 29 (2), 285-296, 2010
The global burden of lung cancer: current status and future trends
A Leiter, RR Veluswamy, JP Wisnivesky
Nature Reviews Clinical Oncology 20 (9), 624-639, 2023
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
D Yin, S Ogawa, N Kawamata, A Leiter, M Ham, D Li, NB Doan, JW Said, ...
Oncogene 32 (9), 1155-1163, 2013
Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel
HH Cheng, R Gulati, A Azad, R Nadal, P Twardowski, UN Vaishampayan, ...
Prostate cancer and prostatic diseases 18 (2), 122-127, 2015
Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis
W Chien, J O'Kelly, D Lu, A Leiter, J Sohn, D Yin, B Karlan, J Vadgama, ...
International journal of oncology 38 (6), 1741-1747, 2011
Clinical trial awareness: Changes over time and sociodemographic disparities
A Leiter, MA Diefenbach, J Doucette, WK Oh, MD Galsky
Clinical Trials 12 (3), 215-223, 2015
Cutaneous papilloma and squamous cell carcinoma therapy utilizing nanosecond pulsed electric fields (nsPEF)
D Yin, WG Yang, J Weissberg, CB Goff, W Chen, Y Kuwayama, A Leiter, ...
Public Library of Science 7 (8), e43891, 2012
Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation
A Kirschenbaum, XH Liu, S Yao, A Leiter, AC Levine
Annals of the New York Academy of Sciences 1237 (1), 64-70, 2011
Use of crowdsourcing for cancer clinical trial development
A Leiter, T Sablinski, M Diefenbach, M Foster, A Greenberg, J Holland, ...
Journal of the National Cancer Institute 106 (10), dju258, 2014
Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines
W Chen, A Leiter, D Yin, M Meiring, VJ Louw, HP Koeffler
International journal of oncology 37 (3), 737-743, 2010
Telemedicine-enabled clinical trial of metformin in patients with prostate cancer
MD Galsky, M Shahin, R Jia, DR Shaffer, K Gimpel-Tetra, CK Tsao, ...
JCO clinical cancer informatics 1, 1-10, 2017
Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis
S Thapi, A Leiter, M Galsky, EJ Gallagher
Journal for ImmunoTherapy of Cancer 7, 1-5, 2019
Metabolic effects of JAK1/2 inhibition in patients with myeloproliferative neoplasms
M Sapre, D Tremblay, E Wilck, A James, A Leiter, A Coltoff, AG Koshy, ...
Scientific Reports 9 (1), 16609, 2019
The effect of prior abiraterone (Abi) use on the activity of enzalutamide (Enza) in men with mCRPC.
HH Cheng, R Nadal, R Gulati, A Azad, P Twardowski, UN Vaishampayan, ...
Journal of Clinical Oncology 32 (4_suppl), 18-18, 2014
Metabolic disease and adverse events from immune checkpoint inhibitors
A Leiter, E Carroll, S De Alwis, D Brooks, J Ben Shimol, E Eisenberg, ...
European journal of endocrinology 184 (6), 857-865, 2021
Assessing the association of diabetes with lung cancer risk
A Leiter, A Charokopos, S Bailey, EJ Gallagher, FR Hirsch, D LeRoith, ...
Translational Lung Cancer Research 10 (11), 4200, 2021
Obesity and outcomes in patients with metastatic urothelial carcinoma
A Leiter, J Doucette, S Krege, CC Lin, N Hahn, T Ecke, G Sonpavde, ...
Bladder cancer 2 (3), 341-349, 2016
Characterization of hyperglycemia in patients receiving immune checkpoint inhibitors: Beyond autoimmune insulin-dependent diabetes
A Leiter, E Carroll, D Brooks, JB Shimol, E Eisenberg, JP Wisnivesky, ...
Diabetes research and clinical practice 172, 108633, 2021
A common pituitary autoantibody in two patients with immune checkpoint inhibitor-mediated hypophysitis: ZCCHC8
A Leiter, S Gnjatic, M Fowkes, S Kim-Schulze, I Laface, MD Galsky, ...
AACE Clinical Case Reports 6 (4), e151-e160, 2020
Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade
KK Sindhu, A Leiter, E Moshier, JY Lin, E Carroll, D Brooks, JB Shimol, ...
Cancer treatment and research communications 25, 100216, 2020
The system can't perform the operation now. Try again later.
Articles 1–20